These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 26113054)
1. AT-101 inhibits hedgehog pathway activity and cancer growth. Wang J; Peng Y; Liu Y; Yang J; Huang M; Tan W Cancer Chemother Pharmacol; 2015 Sep; 76(3):461-9. PubMed ID: 26113054 [TBL] [Abstract][Full Text] [Related]
2. Identification of pseudolaric acid B as a novel Hedgehog pathway inhibitor in medulloblastoma. Wei SF; He DH; Zhang SB; Lu Y; Ye X; Fan XZ; Wang H; Wang Q; Liu YQ Biochem Pharmacol; 2021 Aug; 190():114593. PubMed ID: 33964282 [TBL] [Abstract][Full Text] [Related]
3. Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth. Wang J; Peng Y; Liu Y; Yang J; Ding N; Tan W BMC Cancer; 2015 Aug; 15():595. PubMed ID: 26296751 [TBL] [Abstract][Full Text] [Related]
4. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor. Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740 [TBL] [Abstract][Full Text] [Related]
5. CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway. Chen J; Lv H; Hu J; Ji M; Xue N; Li C; Ma S; Zhou Q; Lin B; Li Y; Yu S; Chen X Cancer Lett; 2016 Oct; 381(2):391-403. PubMed ID: 27495899 [TBL] [Abstract][Full Text] [Related]
6. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma. Gordon RE; Zhang L; Peri S; Kuo YM; Du F; Egleston BL; Ng JMY; Andrews AJ; Astsaturov I; Curran T; Yang ZJ Clin Cancer Res; 2018 Mar; 24(6):1375-1388. PubMed ID: 29437795 [No Abstract] [Full Text] [Related]
7. Cynanbungeigenin C and D, a pair of novel epimers from Cynanchum bungei, suppress hedgehog pathway-dependent medulloblastoma by blocking signaling at the level of Gli. Li XY; Zhou LF; Gao LJ; Wei Y; Xu SF; Chen FY; Huang WJ; Tan WF; Ye YP Cancer Lett; 2018 Apr; 420():195-207. PubMed ID: 29425683 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 Inhibits Wu F; Zhang C; Zhao C; Wu H; Teng Z; Jiang T; Wang Y Cancer Res; 2020 Jul; 80(13):2818-2832. PubMed ID: 32371475 [TBL] [Abstract][Full Text] [Related]
9. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma. Filocamo G; Brunetti M; Colaceci F; Sasso R; Tanori M; Pasquali E; Alfonsi R; Mancuso M; Saran A; Lahm A; Di Marcotullio L; Steinkühler C; Pazzaglia S Mol Cancer Ther; 2016 Jun; 15(6):1177-89. PubMed ID: 26960983 [TBL] [Abstract][Full Text] [Related]
10. Smoothened-activating lipids drive resistance to CDK4/6 inhibition in Hedgehog-associated medulloblastoma cells and preclinical models. Daggubati V; Hochstelter J; Bommireddy A; Choudhury A; Krup AL; Kaur P; Tong P; Li A; Xu L; Reiter JF; Raleigh DR J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33476305 [TBL] [Abstract][Full Text] [Related]
11. A sterol analog inhibits hedgehog pathway by blocking cholesterylation of smoothened. Liu YB; He LM; Sun M; Luo WJ; Lin ZC; Qiu ZP; Zhang YL; Hu A; Luo J; Qiu WW; Song BL Cell Chem Biol; 2024 Jul; 31(7):1264-1276.e7. PubMed ID: 38442710 [TBL] [Abstract][Full Text] [Related]
12. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma. Infante P; Malfanti A; Quaglio D; Balducci S; De Martin S; Bufalieri F; Mastrotto F; Basili I; Garofalo M; Lospinoso Severini L; Mori M; Manni I; Moretti M; Nicoletti C; Piaggio G; Caliceti P; Botta B; Ghirga F; Salmaso S; Di Marcotullio L Cancer Lett; 2021 Feb; 499():220-231. PubMed ID: 33249196 [TBL] [Abstract][Full Text] [Related]
13. mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma. Wu CC; Hou S; Orr BA; Kuo BR; Youn YH; Ong T; Roth F; Eberhart CG; Robinson GW; Solecki DJ; Taketo MM; Gilbertson RJ; Roussel MF; Han YG Dev Cell; 2017 Dec; 43(6):673-688.e5. PubMed ID: 29103956 [TBL] [Abstract][Full Text] [Related]
14. A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma. Shou Y; Robinson DM; Amakye DD; Rose KL; Cho YJ; Ligon KL; Sharp T; Haider AS; Bandaru R; Ando Y; Geoerger B; Doz F; Ashley DM; Hargrave DR; Casanova M; Tawbi HA; Rodon J; Thomas AL; Mita AC; MacDonald TJ; Kieran MW Clin Cancer Res; 2015 Feb; 21(3):585-93. PubMed ID: 25473003 [TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold. Berardozzi S; Bernardi F; Infante P; Ingallina C; Toscano S; De Paolis E; Alfonsi R; Caimano M; Botta B; Mori M; Di Marcotullio L; Ghirga F Eur J Med Chem; 2018 Aug; 156():554-562. PubMed ID: 30025349 [TBL] [Abstract][Full Text] [Related]
17. RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism. Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254 [TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Elamin MH; Shinwari Z; Hendrayani SF; Al-Hindi H; Al-Shail E; Khafaga Y; Al-Kofide A; Aboussekhra A Mol Carcinog; 2010 Mar; 49(3):302-14. PubMed ID: 20025076 [TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity. Lu W; Liu Y; Ma H; Zheng J; Tian S; Sun Z; Luo L; Li J; Zhang H; Yang ZJ; Zhang X ACS Chem Neurosci; 2017 Sep; 8(9):1980-1994. PubMed ID: 28618224 [TBL] [Abstract][Full Text] [Related]